Funded Research
Since 2010, the Snowdome Foundation has committed a total of $55 million towards cutting-edge blood cancer research.
This funding has supported 70 research projects and facilitated the creation of over 101 research positions.
Snowdome is the leading not-for-profit focused exclusively on translational research, where scientific findings are used to
advance the development of innovative diagnostic tools and treatments. We have a keen interest in research
that accelerates next-generation treatments and advances precision therapy including genomic testing,
targeted therapies and immune therapies. We fund both research and clinical trials.
Grants
Through the incredible generosity of our philanthropic donors and partners, the Snowdome Foundation can provide Australia’s best clinicians and researchers with much-needed funding to support their work.
To view current grant calls, click here.
In 2024, Snowdome awarded the following grants to exceptional researchers pursuing innovative approaches to blood cancer research and treatments.
- Associate Professor Paul Beavis: LLS-Snowdome Foundation Translational Research Program
- Muhammed B. Sabdia: Gunn Family Haematology Fellowship
- Dr Edward Cliff: Cannon Family Travel Grant
- Dr Hansen Kosasih: Cannon Family Travel Grant
